Zoetis Inc. sees strong growth with steady buybacks and key franchises thriving. Click for why the ZTS problems related to ...

Some luxury labels are pulling back from steep markdowns in China, seeking to rebuild an image of exclusivity to lure back ...

They say they're worried how the company's messaging will affect their futures.

TORONTO, ON / ACCESS Newswire / May 9, 2025 / CCL Industries Inc. (TSX:CCL.A)(TSX:CCL.B) (the "Company" or "CCL"), a world leader in specialty label, security and packaging solutions for global corpor ...

Valneva SE offers exposure to a robust travel vaccine portfolio that includes Ixiaro, Dukoral, and Ixchiq. Read what ...

General and Administrative (G&A) Expenses. G&A expenses for the three months ended March 31, 2025 were $6.9 million compared to $5.1 million for the same period in 2024. The increase was primarily ...

It’s a well-worn piece of frugal advice for those looking to save money in times of economic hardship: Buy generic instead of ...

We believe Kenvue is in fine financial health. The firm ended 2024 with about $1.1 billion in cash and $8.6 billion in debt. Despite the large debt balance compared with its current level of cash, we ...

Research and development expenses for the first quarter of 2025 were $42.9 million versus $20.7 million for the comparable ...

In April 2025, our partner Jazz announced that the European Medicines Agency (EMA) Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion recommending the approval of ...